scholarly article | Q13442814 |
P2093 | author name string | P Jolicoeur | |
P S Rudland | |||
R Barraclough | |||
L Robertson | |||
E W Parry | |||
M P Davies | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1631-1637 | |
P577 | publication date | 1996-10-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours | |
P478 | volume | 13 |
Q33312065 | A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics |
Q28306743 | A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4 |
Q30839846 | A role for CCN3 (NOV) in calcium signalling |
Q27678348 | Asymmetric Mode of Ca2+-S100A4 Interaction with Nonmuscle Myosin IIA Generates Nanomolar Affinity Required for Filament Remodeling |
Q37097531 | Calcium-binding S100 protein expression in pterygium |
Q33738159 | Cancer stem cells are enriched in the side population cells in a mouse model of glioma |
Q33941301 | Characterization of Sp1, AP-1, CBF and KRC binding sites and minisatellite DNA as functional elements of the metastasis-associated mts1/S100A4 gene intronic enhancer |
Q27678260 | Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism |
Q89741538 | Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell migration without changes in cell adhesion |
Q37554595 | Distinct prognostic values of S100 mRNA expression in breast cancer |
Q79316045 | Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer |
Q30961562 | Expression of calcium-binding protein S100A2 in breast lesions |
Q38637559 | Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers |
Q36294873 | Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells |
Q74636099 | Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines |
Q24652731 | Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin |
Q45004417 | Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence lifetime imaging microscopy. |
Q34551546 | Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis |
Q38118075 | Joining S100 proteins and migration: for better or for worse, in sickness and in health. |
Q36857449 | Modeling metastatic breast cancer in mice |
Q42285471 | Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers |
Q33481737 | Molecular dynamics simulation of S100B protein to explore ligand blockage of the interaction with p53 protein |
Q34553964 | Mouse models of breast cancer metastasis |
Q92269542 | Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction |
Q38792223 | PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair |
Q37237675 | Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer |
Q41867135 | Protein S100A4: too long overlooked by pathologists? |
Q33935212 | Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor |
Q36955141 | Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells |
Q58086680 | S100 proteins as therapeutic targets |
Q35206368 | S100 proteins in cancer |
Q43200588 | S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma |
Q38281887 | S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. |
Q37660289 | S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer |
Q47953375 | S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma |
Q33597019 | S100A4 and metastasis: a small actor playing many roles |
Q42700673 | S100A4 in cancer progression and metastasis: A systematic review |
Q36166931 | S100A4 in esophageal cancer: is this the one to blame? |
Q36673631 | S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis |
Q30495765 | S100A4 regulates macrophage chemotaxis |
Q35210979 | S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells |
Q37103177 | S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? |
Q37502777 | Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth |
Q39584443 | Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. |
Q40840775 | Stathmin is involved in S100A4-mediated regulation of cell cycle progression |
Q35047058 | Structure of the S100A4/myosin-IIA complex |
Q36339222 | Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation. |
Q34556703 | The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells |
Q36131038 | The metastasis associated protein S100A4: role in tumour progression and metastasis |
Q36814092 | The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis |
Q42481244 | The role of S100 genes in breast cancer progression |
Q40751670 | Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer |
Q35582533 | Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion |
Q34784895 | Use of proteins as biomarkers and their role in carcinogenesis. |
Search more.